Correlation Between Cellectis and Mosaic Immunoengineerin

Can any of the company-specific risk be diversified away by investing in both Cellectis and Mosaic Immunoengineerin at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cellectis and Mosaic Immunoengineerin into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Cellectis SA and Mosaic Immunoengineering, you can compare the effects of market volatilities on Cellectis and Mosaic Immunoengineerin and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cellectis with a short position of Mosaic Immunoengineerin. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cellectis and Mosaic Immunoengineerin.

Diversification Opportunities for Cellectis and Mosaic Immunoengineerin

0.47

Correlation Coefficient

Cellectis  Mosaic Immunoengineerin

Very weak diversification

The 3 months correlation between Cellectis and Mosaic is 0.47. Overlapping area represents the amount of risk that can be diversified away by holding Cellectis SA and Mosaic Immunoengineering in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mosaic Immunoengineering and Cellectis is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cellectis SA are associated (or correlated) with Mosaic Immunoengineerin. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mosaic Immunoengineering has no effect on the direction of Cellectis i.e., Cellectis and Mosaic Immunoengineerin go up and down completely randomly.

Pair Corralation between Cellectis and Mosaic Immunoengineerin

Assuming the 90 days horizon Cellectis is expected to generate 48.81 times less return on investment than Mosaic Immunoengineerin. But when comparing it to its historical volatility, Cellectis SA is 10.96 times less risky than Mosaic Immunoengineerin. It trades about 0.03 of its potential returns per unit of risk. Mosaic Immunoengineering is currently generating about 0.12 of returns per unit of risk over similar time horizon. If you would invest  50.00  in Mosaic Immunoengineering on February 3, 2024 and sell it today you would earn a total of  10.00  from holding Mosaic Immunoengineering or generate 20.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Cellectis SA  vs.  Mosaic Immunoengineering

Cellectis SA

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Cellectis SA has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest uncertain performance, the Stock's essential indicators remain stable and the current disturbance on Wall Street may also be a sign of long-run gains for the company stockholders.

Mosaic Immunoengineering

Risk-Adjusted Performance

6 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Mosaic Immunoengineering are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of fairly uncertain primary indicators, Mosaic Immunoengineerin showed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Cellectis and Mosaic Immunoengineerin

The main advantage of trading using opposite Cellectis and Mosaic Immunoengineerin positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cellectis position performs unexpectedly, Mosaic Immunoengineerin can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mosaic Immunoengineerin will offset losses from the drop in Mosaic Immunoengineerin's long position.

The idea behind Cellectis SA and Mosaic Immunoengineering pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.